Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Tyrosine Kinase Receptor With Extensive Homology To EGF Receptor Shares Chromosomal Location With Neu Oncogene.
L. Coussens, T. Yang-Feng, Y. C. Liao, E. Chen, A. Gray, J. McGrath, P. Seeburg, T. Libermann, J. Schlessinger, U. Francke
Published 1985 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
A novel potential cell surface receptor of the tyrosine kinase gene family has been identified and characterized by molecular cloning. Its primary sequence is very similar to that of the human epidermal growth factor receptor and the v-erbB oncogene product; the chromosomal location of the gene for this protein is coincident with the neu oncogene, which suggests that the two genes may be identical.
This paper references
The membrane glycoprotein encoded by the retroviral oncogene v-erb-B is structurally related to tyrosine-specific protein kinases.
M. Privalsky (1984)
Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase.
J. Taylor (1976)
Epidermal growth factor: Is the precursor a receptor?
S. Pfeffer (1985)
Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.
G. Wahl (1979)
Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells.
G. Merlino (1984)
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
Alan L. Schechter (1984)
The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
Tokuo J. Yamamoto (1984)
The erbB gene of avian erythroblastosis virus is a member of the src gene family
T. Yamamoto (1983)
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
A. Ullrich (1985)
Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane
T. Hunter (1984)
Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins.
J. Scott (1983)
Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system
M. Kasuga (1982)
The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1
C. Sherr (1985)
Production of an epidermal growth factor receptor-related protein.
W. Weber (1984)
Random X inactivation resulting in mosaic nullisomy of region Xp21.1----p21.3 associated with heterozygosity for ornithine transcarbamylase deficiency and for chronic granulomatous disease.
U. Francke (1984)
Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor
B. Ek (1982)
Monoclonal antibodies to the transformation-specific glycoprotein encoded by the feline retroviral oncogene v-fms.
S. Anderson (1982)
The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor.
A. Schechter (1985)
DNA sequencing with chain-terminating inhibitors.
F. Sanger (1977)
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts
C. Shih (1981)
Insulin receptor: evidence that it is a protein kinase.
R. Roth (1983)
Requirement of the human chromosome 11 long arm for replication of herpes simplex virus type 1 in nonpermissive Chinese hamster x human diploid fibroblast hybrids
U. Francke (1981)
Cell surface expression of the mcdonough strain of feline sarcoma virus fms gene product (gp140fms)
R. Manger (1984)
A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments.
J. Messing (1982)
Insulin activates a tyrosine-specific protein kinase in extracts of 3T3-L1 adipocytes and human placenta.
L. Petruzzelli (1982)
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
J. Downward (1984)
Autophosphorylation sites on the epidermal growth factor receptor
J. Downward (1984)
Synthesis of oligonucleotides on cellulose by a phosphotriester method.
R. Crea (1980)
The isolation and characterization of linked δ- and β-globin genes from a cloned library of human DNA
R. M. Lawn (1978)
A simple method for displaying the hydropathic character of a protein.
J. Kyte (1982)
Phosphate‐binding sequences in nucleotide‐binding proteins
W. Möller (1985)
Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I
J. Rubin (1983)
Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus
M. Waterfield (1983)
Characterization of insulin-mediated phosphorylation of the insulin receptor in a cell-free system.
Y. Zick (1983)
Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor
A. Gray (1983)
The beta subunit of the insulin receptor is an insulin-activated protein kinase.
M. Shia (1983)
Viral src gene products are related to the catalytic chain of mammalian cAMP-dependent protein kinase.
W. C. Barker (1982)
Gel electrophoresis of restriction fragments.
E. Southern (1979)
Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor.
M. Kasuga (1982)
A system for shotgun DNA sequencing.
J. Messing (1981)
High resolution of human chromosomes.
J. Yunis (1976)
Amplification of a novel v-erbB-related gene in a human mammary carcinoma.
C. R. King (1985)
RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.
H. Lehrach (1977)
Insulin stimulation of phosphorylation of the beta subunit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine.
M. Kasuga (1982)
Modelling the ATP‐binding site of oncogene products, the epidermal growth factor receptor and related proteins
M. Sternberg (1984)
Transmembrane orientation of glycoproteins encoded by the v-fms oncogene
C. W. Rettenmier (1985)
Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor.
R. Doolittle (1983)
Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes.
M. Kozak (1981)
Assignment of the major histocompatibility complex to a region of the short arm of human chromosome 6.
U. Francke (1977)
Somatomedin-C stimulates the phosphorylation of the beta-subunit of its own receptor.
S. Jacobs (1983)
Molecular cloning of the avian erythroblastosis virus genome and recovery of oncogenic virus by transfection of chicken cells.
B. Vennström (1980)
Receptor-mediated phosphorylation of the hepatic insulin receptor: evidence that the Mr 95,000 receptor subunit is its own kinase.
E. Van Obberghen (1983)
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
A. Ullrich (1984)
This paper is referenced by
Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma.
A. Zekri (2000)
The duration of phorbol-inducible ErbB2 tyrosine dephosphorylation parallels that of receptor endocytosis rather than threonine-686 phosphorylation: implications for the physiological role of protein kinase C in growth factor receptor signalling.
X. Ouyang (1998)
Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.
J. Codony-Servat (1999)
Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour.
T. Andersen (1995)
Oncogenic Neu/ErbB-2 Increases Ets, AP-1, and NF-B-dependent Gene Expression, and Inhibiting Ets Activation Blocks Neu-mediated Cellular Transformation (*)
C. K. Galang (1996)
Overexpression of HER2/neu oncogene in human pancreatic carcinoma.
Y. Yamanaka (1993)
Ultrasensitive plasmid mapping by high performance capillary electrophoresis
H. Maschke (1993)
Oncogene Products as Receptors
E. Sibinga (1987)
The insulin receptor: structure and function.
Y. Zick (1989)
Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms.
J. Day (1996)
3 Mechanisms of growth regulation of human breast cancer
A. Wakeling (1990)
Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras‐GTP‐ase activating protein in Caco‐2 cells
A. Auricchio (1994)
neu/HER‐2 cDNA Vaccination and Pregnancy Loss
F. Venanzi (1995)
Estudio de la expresión del antígeno nuclear de proliferación celular y pl85 en el carcinoma no microcítico de pulmón
P. A. Monraval (1996)
Beta-amyloid precursor protein. Location of transmembrane domain and specificity of gamma-secretase cleavage.
E. Tischer (1996)
Breast cancer metastasis-associated genes : Prognostic significance and therapeutic implications
Moustafa As (1997)
p34cdc2 in invasive breast cancer: relationship to DNA content, Ki67 index and c‐erbB‐2 expression
Breast Cancer Trials
D. Slamon (2001)
Mechanism of action of anti-HER2 monoclonal antibodies.
J. Baselga (2001)
Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
T. Brodowicz (2001)
Antibodies as molecular target-based therapy: trastuzumab
Y. Tokuda (2002)
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
D. Yoon (2011)
Carcinomas and Melanomas CTL Against Autologous and Allogeneic Peptide Epitopes That Can Elicit Specific Derived neu-Identification of New HER 2 /
Y. Rongcun (1999)
Downregulation of HER 2 by RIG 1 involves the PI 3 K / Akt pathway in ovarian cancer cells
Chien-Chih Ou (2008)
HER2 mutations in Moroccan lung adenocarcinoma patients
Ibrahim Elghissassi (2014)
Feline Mammary Carcinoma: Past, Present and Future
A. Gameiro (2020)
Production of Antibodies in Hybridoma and Non-hybridoma Cell Lines
S. Mcdonnell (2015)
Herceptin® Alone or in Combination with Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Pivotal Trials
J. Baselga (2001)
Affinity-reversed-phase liquid chromatography assay to quantitate recombinant antibodies and antibody fragments in fermentation broth.
J. Battersby (2001)
Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma
H. Safran (2001)
Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
P. Rudolph (2001)
HER‐Kinase‐Directed Therapy of Prostate Cancer
D. Solit (2001)See more